Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Sales | 1,054,600 | 1,080,177 | 1,025,738 | 970,638 | 960,176 |
| Cost of Goods | 127,562 | 118,529 | 108,982 | 94,816 | 70,176 |
| Gross Profit | 927,038 | 961,648 | 916,756 | 875,822 | 890,000 |
| Operating Expenses | 744,095 | 715,044 | 685,943 | 663,410 | 616,458 |
| Operating Income | 183,505 | 247,133 | 231,795 | 213,228 | 273,718 |
| Interest Expense | 198 | 127 | 125 | 183 | -183 |
| Other Income | 13,067 | 8,139 | 4,234 | 32,737 | 2,198 |
| Pre-tax Income | 196,374 | 255,145 | 235,904 | 245,782 | 276,099 |
| Income Tax | 154,069 | 48,039 | 49,502 | 62,542 | 67,379 |
| Net Income Continuous | 42,305 | 207,106 | 186,402 | 183,240 | 208,720 |
| Minority Interests | 559 | 625 | 542 | 1,850 | 2,617 |
| Net Income | $41,746 | $206,481 | $185,860 | $181,390 | $206,103 |
| EPS Basic Total Ops | 0.40 | 2.03 | 1.85 | 1.77 | 2.02 |
| EPS Basic Continuous Ops | 0.41 | 2.03 | 1.85 | 1.79 | 2.04 |
| EPS Diluted Total Ops | 0.39 | 2.00 | 1.81 | 1.75 | 1.99 |
| EPS Diluted Continuous Ops | 0.40 | 2.01 | 1.82 | 1.76 | 2.01 |
| EPS Diluted Before Non-Recurring Items | 2.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $267,261 | $334,199 | $320,771 | $291,523 | $336,394 |